Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[In Vitro Identification and Characteristics of CD34- Leukemia Stem Cell in t(8;21) Acute Myeloid Leukemia]Yan-Huan Zhang, Lu Yang, Ya-Zhe Wang, et al.
Leukemia Research|March 21, 2016
Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)Hong-Hu Zhu, Hao Jiang, Qian Jiang, et al.
Zhonghua Nei Ke Za Zhi|August 8, 2008
[Bortezomib-based combination therapy for newly diagnosed multiple myeloma]Li Bao, Xi-jin Lu, Xiao-hui Zhang, et al.
Leukemia Research|September 22, 2017
The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemiaFang Wang, Jin-Song Jia, Jing Wang, et al.
Journal of Clinical Apheresis|April 26, 2012
Dynamics of monocyte count: a good predictor for timing of peripheral blood stem cell collectionShen-Miao Yang, Huan Chen, Yu-Hong Chen, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysisXiaotong Yu, Liping Liu, Zhenwei Xie, et al.
Cellular and Molecular Life Sciences : CMLS|May 27, 2022
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARαXinping Huang, Yongfeng Yang, Dan Zhu, et al.
Cancer|March 7, 2023
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaMixue Xie, Ting Shi, Qi Jiang, et al.
Biochemical and Biophysical Research Communications|March 3, 2019
Identification of a point mutation PMLS214L-RARα that alters PML body organization, dynamics and SUMOylationShanshan Zhao, Peng Shi, Qihang Zhong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 8, 2003
[Specific anti-leukemic cell effect mediated by dendritic cells pulsed with chronic myelogenous leukemia lysate antigen in vitro]Hong-Hu Zhu, Kai-Lin Xu, Xiu-Ying Pan, et al.
Pageof 13